Ilioinguinal Block in Laparoscopic Inguinal Hernia Repair
NCT ID: NCT01969006
Last Updated: 2014-12-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
PHASE2
INTERVENTIONAL
2014-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Patients will be randomised to injection of Marcaine© og a needle prick per-operatively.
Pain will be estimated using the VAS score in:
1\. the wound 2 the abdomen 3 the shoulder
Scoring will be performed:
1. pre-operatively
2. 1 hour postoperatively
3. at discharge from the hospital d day 1,2 and 3 post OP
e. 1 year post OP
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Injection of Marcaine ½ %
Injection of 40 ml of Marcaine ½ % 2 cm medial, 2 cm downwards from the Anterior Iliac Spine
Marcaine ½%
Needle prick
Needle prick 2 cm medial and 2 cm downwards from the Anterior Iliac spine
Needle prick
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Marcaine ½%
Needle prick
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Informed consent
3. a diagnosis of an inguinal hernia
4. ASA group ≤ 3
5. BMI ≤ 35
Exclusion Criteria
2. No consent
3. Open procedure (not laparoscopic)
4. ASA-group 4
5. Use of Steroid or immunosuppressive tretament
6. Regular morphine use.
18 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Regionshospitalet Horsens
OTHER
Denmark
UNKNOWN
Randers Regional Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Thorbjorn Sommer
Senior Surgeon phd, ass proffessor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Horsens Regions Hospital
Horsens, , Denmark
Randers regions Hospital
Randers, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ILIOINGUINAL01
Identifier Type: -
Identifier Source: org_study_id